Article Text

Download PDFPDF
Extended report
Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis
  1. Denis Poddubnyy1,
  2. Martin Rudwaleit2,
  3. Hildrun Haibel1,
  4. Joachim Listing3,
  5. Elisabeth Märker-Hermann4,
  6. Henning Zeidler5,
  7. Jürgen Braun6,
  8. Joachim Sieper1
  1. 1Department of Rheumatology, Charité–Campus Benjamin Franklin, Berlin, Germany
  2. 2Department of Rheumatology, Evangelisches Krankenhaus Hagen-Haspe, Hagen, Germany
  3. 3Department of Epidemiology, German Rheumatism Research Centre, Berlin, Germany
  4. 4Dr Horst Schmidt Kliniken, Wiesbaden, Germany
  5. 5Medizinische Hochschule Hannover, Hannover, Germany
  6. 6Rheumazentrum Ruhrgebiet, Herne, Germany
  1. Correspondence to Joachim Sieper, Medical Department I, Rheumatology, Charité–Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany; joachim.sieper{at}charite.de

Footnotes

  • Funding As part of the German competence network in rheumatology (Kompetenznetz Rheuma), GESPIC has been financially supported by the German Ministry for Education and Research (Bundesministerium für Bildung und Forschung–BMBF), grant number: FKZ01G19946. As funding by BMBF was reduced according to schedule in 2005, complementary financial support in equal parts has been obtained since 2005 from Amgen, Centocor, Schering-Plough and Wyeth, and since 2006 also from Abbott Immunology.

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval The study protocol was approved by the central ethical committee of the coordinating centre (Charité–Campus Benjamin Franklin, Berlin, Germany) and by all local ethical committees of the participating centres.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Funding As part of the German competence network in rheumatology (Kompetenznetz Rheuma), GESPIC has been financially supported by the German Ministry for Education and Research (Bundesministerium für Bildung und Forschung–BMBF), grant number: FKZ01G19946. As funding by BMBF was reduced according to schedule in 2005, complementary financial support in equal parts has been obtained since 2005 from Amgen, Centocor, Schering-Plough and Wyeth, and since 2006 also from Abbott Immunology.

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval The study protocol was approved by the central ethical committee of the coordinating centre (Charité–Campus Benjamin Franklin, Berlin, Germany) and by all local ethical committees of the participating centres.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.